Skip to main content

dtx

By Dave Muoio | 10:00 am | February 24, 2021
The randomized controlled trial of the jointly-developed digital therapeutics will be conducted using Verily's Project Baseline and enroll up to 540 patients. 
By Dave Muoio | 04:50 pm | February 12, 2021
MobiHealthNews spoke with Pear Therapeutics, Click Therapeutics and DTx newcomer Mahana Therapeutics to discuss whether in-licensing is the way to go for those just entering the space.
By Jonah Comstock | 02:59 pm | January 13, 2021
The results will not impact the current rollout of a new version of the app, under special FDA guidelines.
By Dave Muoio | 04:16 pm | December 14, 2020
The London-based company is backing a 300-person UPenn study comparing its digital therapeutic to the consumer wellness app.
By Dave Muoio | 01:14 pm | December 08, 2020
The company currently has three prescription digital therapeutics available on the market.
By Laura Lovett | 01:01 pm | November 10, 2020
Professional health organizations make statements on the new administration. 
By Dave Muoio | 03:47 pm | November 09, 2020
NightWare's digital therapeutic monitors a wearer's heart rate and movement to detect disturbances during sleep, and delivers gentle vibrations to interrupt a nightmare without waking the user.
By Dave Muoio | 02:55 pm | November 05, 2020
The study, backed by the digital therapeutics company, measured the change in clinical encounter frequency among opioid use disorder patients who were also prescribed buprenorphine.
By Dave Muoio | 05:53 pm | September 11, 2020
The companies will be collaborating on a prescription digital therapeutic for patients with schizophrenia built on Click Therapeutics' tech platform.
By Dave Muoio | 02:40 pm | August 31, 2020
The new analysis of a Pear Therapeutics-based randomized controlled trial came alongside another investigation that spotted early signs of treatment dropout.